Clinical Trial Detail

NCT ID NCT04396821
Title A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mabspace Biosciences (Suzhou) Co., Ltd.
Indications

stomach cancer

Advanced Solid Tumor

lung cancer

ovarian cancer

gastroesophageal junction adenocarcinoma

cholangiocarcinoma

pancreatic cancer

Therapies

TST001

Age Groups: senior adult

No variant requirements are available.